We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Rejuvenation of Aging Cells in Osteoarthritis Gene Therapy
News

Rejuvenation of Aging Cells in Osteoarthritis Gene Therapy

Rejuvenation of Aging Cells in Osteoarthritis Gene Therapy
News

Rejuvenation of Aging Cells in Osteoarthritis Gene Therapy

CBX4 maintains nucleolar homeostasis, alleviates senescence and osteoarthritis. Credit: Institute of Zoology
Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Rejuvenation of Aging Cells in Osteoarthritis Gene Therapy"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Aging is a risk factor for the development of osteoarthritis (OA), a chronic disease characterized by degeneration of articular cartilage leading to pain and physical disability. Senescent mesenchymal stem cells (hMSCs) are found in cartilage tissues isolated from patients suffering from osteoarthritis. Notably, senescent MSCs have been regarded as an important therapeutic target for geroprotection against tissue degeneration.

Recently, in a study published in Cell Reports, scientists found that a protein factor, CBX4, could help to cure osteoarthritis in mice, after four years of work.

These scientists, from the Institute of Zoology of the Chinese Academy of Sciences (CAS), Peking University and the Institute of Biophysics of CAS, found that CBX4 safeguarded hMSCs against cellular senescence through the regulation of nucleolar architecture and function.

Importantly, CBX4 overexpression attenuated the development of osteoarthritis in mice, suggesting a target for therapeutic interventions against aging-associated disorders.

CBX4, a component of polycomb repressive complex 1 (PRC1), plays an important role in the regulation of cell identity and organ development through gene silencing.

CBX4 protein was downregulated in aged hMSCs whereas CBX4 knockout in hMSCs resulted in destabilized nucleolar heterochromatin, enhanced ribosome biogenesis, increased protein translation, and accelerated cellular senescence.

CBX4 maintained nucleolar homeostasis by recruiting nucleolar protein fibrillarin and heterochromatin protein KRAB-associated protein 1 (KAP1) at nucleolar rDNA, limiting the excessive expression of rRNAs.

Importantly, overexpression of CBX4 alleviated physiological hMSC aging and attenuated the development of osteoarthritis in mice.

These findings not only highlight that CBX4-mediated nucleolar homeostasis is a key gatekeeper for hMSC aging. They also open an avenue for preventing aging-associated stem cell exhaustion and, hopefully, treating age-related disorders in the future.

Taken together, the researchers revealed a new mechanism for the nucleolar protein CBX4 in maintaining hMSC homeostasis.

These findings prove the feasibility of using gene therapy strategies to rejuvenate senescent cells and treat osteoarthritis, providing a promising option for future geriatrics and regenerative medicine.

This article has been republished from materials provided by the Institute of Zoology of the Chinese Academy of Sciences . Note: material may have been edited for length and content. For further information, please contact the cited source.

Reference: Ren et al. 2019. Maintenance of Nucleolar Homeostasis by CBX4 Alleviates Senescence and Osteoarthritis. Cell Reports. DOI:https://doi.org/10.1016/j.celrep.2019.02.088.

Advertisement